Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02882620 · ClinicalTrials.gov registry record · NA
Enhancing Prevention Pathways Toward Tribal Colorectal Health
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 1,788
- Enrollment target
NCT02882620 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 1,788 participants.
The verdict
NCT02882620, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,788 participants
- Enrollment target
Study Summary
Recent improvements in colorectal cancer (CRC) incidence, mortality, stage at diagnosis, and survival in the general U.S. population have been attributed to routine screening with prompt removal of polyps, early detection, and timely and appropriate treatment. American Indians/Alaska Natives (AI/ANs) have not experienced improvements in CRC related outcomes and are significantly less likely than non-Hispanic Whites to receive recommended CRC screening. The purpose of this three-arm randomized controlled trial is to determine the efficacy of interventions designed to enhance CRC screening. The study also uses mixed methods to finalize the intervention and to determine promoters and barriers of screening. The study also conducts process evaluation to determine cost-effectiveness of the interventions, fidelity of study implementation, and to develop plans to sustain and scale-up the intervention model. The study will determine the efficacy of serially implemented interventions of graded intensity for increasing CRC screening using the fecal immunochemical test (FIT) in accordance to recommended guidelines among average risk American Indians (AIs) aged 45-75 residing on reservations in rural Southwestern U.S. Serial implementation refers to offering routine screening, irrespective of response to an earlier invitation, in concordance with guidelines which recommend annual FIT testing between ages 45-75. The FIT is most appropriate because it is an approved, high sensitivity fecal occult blood test and is available at Indian Health Service (IHS) and tribal health facilities where resources to provide screening colonoscopy are limited. The study is a collaborative effort between the Albuquerque Area Indian Health Board (100% Indian-owned and operated), six Pueblo Tribes in rural Southwestern U.S., and the University of New Mexico. Findings from this research could lead to an immediate increase in CRC screening and ultimately reduce CRC burden among AIs, thus addressing nat
Interventions
- BEHAVIORAL High Intensity (Group 1)
- BEHAVIORAL Medium Intensity (Group 2)
- BEHAVIORAL Reference Group (Group 3)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,788 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02882620
The ClinicalTrials.gov registry entry for NCT02882620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,788 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High Intensity (Group 1) is the first listed.
NCT02882620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02882620 about?
NCT02882620 is a clinical study titled "Enhancing Prevention Pathways Toward Tribal Colorectal Health". Recent improvements in colorectal cancer (CRC) incidence, mortality, stage at diagnosis, and survival in the general U.S. population have been attributed to routine screening with prompt removal of polyps, early detection, and timely and appropriate treatment. American Indians/Alaska Natives (AI/ANs...
What is the current status of trial NCT02882620?
This trial is currently completed. It is a NA study. The enrollment target is 1,788 participants. The study started on 2016-10-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT02882620?
The interventions under investigation include: High Intensity (Group 1) (BEHAVIORAL), Medium Intensity (Group 2) (BEHAVIORAL), Reference Group (Group 3) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02882620?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.